The ASAM Criteria is the most widely used standard for matching addiction treatment patients to appropriate levels of care. Six dimensions of patient need and a continuum from outpatient through medically managed inpatient form the framework that payers, accreditors, and clinicians all reference. For treatment center operators, fluency in ASAM is non-negotiable for utilization review, single-case agreements, prior authorization, and admission decisions.
This guide covers what the criteria is, the six dimensions and how they interact, the levels of care continuum, what changed in the 4th edition (2024), how payers use ASAM in authorization decisions, and the documentation discipline that determines whether your authorizations win or lose.
What the ASAM Criteria is
ASAM — the American Society of Addiction Medicine — is the professional medical society for physicians and clinicians who specialize in addiction. The Society has published the ASAM Criteria since 1991 as a consensus clinical framework for placement, continued service, and discharge decisions across the full continuum of addiction treatment.
Over three decades, the criteria became the de facto placement standard. Most state Medicaid agencies, virtually every commercial insurer that pays for addiction treatment, and both major accreditors (TJC and CARF) reference ASAM in their requirements. A treatment center that doesn’t document placement using ASAM dimensions is functionally outside the standard most payers expect.
The criteria has gone through four editions. The 1st edition launched in 1991, the 2nd in 1996, the 3rd in 2013, and the 4th edition was released in 2024 with a substantial reorganization toward a clinical-decision-tree format and integration of newer pharmacotherapy and social-determinant considerations. Adoption of the 4th edition is staggered across payer contracts — some have adopted it formally, some still reference 3rd edition language, and most operators are running both edition standards in parallel during the transition.
The six ASAM dimensions
ASAM placement is multidimensional. Six independent dimensions are assessed at admission and at every continued-stay review. Each dimension scores the severity of patient need in that domain, and the combined picture across all six determines the appropriate level of care. No single dimension drives placement on its own.
Dimension 1: Acute intoxication and/or withdrawal potential. Severity of intoxication on arrival, projected withdrawal trajectory, and history of complicated withdrawal episodes. Programs offering medical detox routinely score this dimension high; outpatient placements require a low score here.
Dimension 2: Biomedical conditions and complications. Co-occurring medical conditions that affect treatment — diabetes, hepatitis, pregnancy, chronic pain, recent surgery, anything that requires medical management alongside addiction treatment. Severe biomedical needs push placement toward higher levels.
Dimension 3: Emotional, behavioral, or cognitive conditions. Co-occurring mental health disorders, cognitive impairment, suicide risk, and behavioral instability. This dimension is the bridge to mental health placement frameworks (LOCUS, CALOCUS) for patients with primary mental health concerns.
Dimension 4: Readiness to change. Stage of change, treatment ambivalence, and engagement potential. A patient with low readiness may need a higher-touch level of care to develop motivation, even when other dimensions would support a lower level.
Dimension 5: Relapse, continued use, or continued problem potential. History of relapse, current craving severity, and the patient’s likelihood of returning to use without structured support. High scores in this dimension typically push placement toward residential or higher.
Dimension 6: Recovery and living environment. Whether the patient’s home and social environment supports recovery. Unstable housing, active use among household members, or a high-risk neighborhood can push placement upward even when clinical factors support lower-level care.
The dimensions interact. A patient with mild withdrawal (Dimension 1 = low) but severe co-occurring depression (Dimension 3 = high), poor readiness (Dimension 4 = high), and an unstable home environment (Dimension 6 = high) would be placed at a higher level of care than dimensions read in isolation would suggest. Dimensional scoring is a tool; clinical judgment integrates the picture.
The ASAM levels of care
ASAM organizes treatment intensity into five core levels (0.5 through 4) with multiple sub-levels in level 3, plus a parallel continuum for withdrawal management.
| Level | Setting | Hours/week | Typical LOS | Use case |
|---|---|---|---|---|
| 0.5 | Early intervention | 1–2 | Variable | Risk reduction, education for at-risk patients not yet meeting SUD criteria |
| 1 | Outpatient services | <9 | 3–12 months | Mild SUD, stable environment, low relapse risk |
| 2.1 | Intensive outpatient (IOP) | 9–19 | 8–12 weeks | Moderate severity, structured support without full-day commitment |
| 2.5 | Partial hospitalization (PHP) | 20+ | 4–8 weeks | Substantial structure, returns home nightly, often a step-down from residential |
| 3.1 | Clinically managed low-intensity residential | Variable | 30–90 days | 24-hour structure, low clinical intensity, peer-recovery emphasis |
| 3.3 | Clinically managed medium-intensity residential | Variable | 30–60 days | Population-specific (cognitive impairment, older adults, complex needs) |
| 3.5 | Clinically managed high-intensity residential | Variable | 30–60 days | High clinical needs, complex psychosocial issues |
| 3.7 | Medically monitored intensive inpatient | Variable | 7–30 days | Significant biomedical or psychiatric instability requiring 24-hour nursing |
| 4 | Medically managed intensive inpatient | Variable | 3–14 days | Severe biomedical or psychiatric instability, hospital-level care |
The withdrawal management continuum runs in parallel: 1-WM through 4-WM, mapping to similar settings for patients whose primary need is acute withdrawal stabilization. A patient may move through 4-WM medically managed withdrawal into 3.7 medically monitored residential into 2.5 PHP into 2.1 IOP across a single episode of care.
The continuum design matters for operator economics: patients move down the continuum as clinical needs decrease, and that step-down progression is usually what payers will authorize across the full treatment episode. Programs that can deliver multiple levels of care internally (or in tight referral networks) capture more of the clinical journey and produce better outcomes data.
How payers use ASAM in authorization decisions
Most commercial payers and Medicaid plans require ASAM-based clinical justification at every authorization touchpoint — initial authorization, concurrent review, and discharge planning. Strong ASAM documentation is the single most important predictor of authorization wins and successful peer-to-peer reviews.
Pre-authorization requires a clinical narrative justifying the requested level of care across all six dimensions. Payers want to see specific patient findings tied to specific dimensions, not generic placement language. “Patient meets ASAM criteria for residential” is not documentation — “Dimension 5 indicates four prior treatment episodes with relapse within 30 days, including two outpatient and two PHP attempts” is.
Concurrent review happens every 3 to 7 days for higher levels of care. Payer reviewers compare the clinical picture today against the dimensional findings at admission and the previous concurrent review. They’re looking for documented progress on the dimensions that justified the original placement and clear reasoning for continued stay or step-down. Programs that update only the relevant dimensions and leave others unchanged often face avoidable denials.
Retrospective review and appeals happen after discharge when payers retroactively challenge authorizations that were granted in real time. Strong dimensional documentation across the entire episode is the foundation of appeals work. When dimensional documentation is thin, appeals are difficult regardless of clinical merit.
The most common documentation pitfalls: vague dimensional language (“patient has co-occurring issues” without specifics), missing dimensions in continued-stay reviews, no clear placement justification when stepping down levels of care, and a disconnect between physician notes and counselor notes that surveyors and reviewers both flag.
ASAM 4th edition (2024) — what changed
The 4th edition (2024) restructured the criteria into a more accessible clinical-decision-tree format. The six dimensions remain, but the navigation through them is simplified and the integration with current pharmacotherapy and social-determinant evidence is deeper.
Key changes operators should understand:
Reorganized clinical decision-tree format. The 4th edition presents placement decisions as a series of dimensional checkpoints, making it easier for clinicians newer to ASAM to navigate to the appropriate level of care. The underlying clinical content is largely consistent with 3rd edition, but the user experience is meaningfully different.
Expanded dimensional assessment for social determinants. Dimension 6 (recovery environment) now explicitly includes social determinants of health — housing stability, food security, transportation access, employment status, justice involvement. Programs that previously addressed these factors loosely now document them within the dimensional framework.
Updated co-occurring guidelines. Dimension 3 guidance reflects current evidence on integrated treatment for co-occurring mental health and SUD, including specific guidance on when integrated care is appropriate vs. when sequential or parallel care is warranted.
Pharmacotherapy considerations integrated. Medication-assisted treatment is no longer treated as a parallel consideration but as integrated within dimensional assessment. The 4th edition aligns ASAM placement with current MAT evidence for opioid use disorder, alcohol use disorder, and stimulant use disorder.
Implementation timeline. Adoption is staggered. Some payers and state Medicaid programs adopted the 4th edition immediately. Others reference the 3rd edition in their current contracts and will transition over the next several years.
ASAM in practice — a typical assessment workflow
The initial ASAM assessment typically happens at intake and runs 60 to 90 minutes for a thorough multidimensional evaluation. A licensed clinical professional — usually a counselor, social worker, or therapist credentialed at the appropriate level — conducts the assessment, scoring each dimension and synthesizing the recommended level of care.
The dimensional scores translate into a placement recommendation. Most programs document this as a clinical narrative referencing the dimensions, the scores, and the reasoning behind the level recommended. The narrative becomes the foundation for the prior-authorization request to the payer.
Reassessment timing varies by level of care. Outpatient and IOP programs typically reassess every 30 to 60 days; PHP every 14 to 30 days; residential every 7 to 14 days; medically monitored or managed inpatient every 24 to 72 hours. Each reassessment produces a new dimensional snapshot that supports continued-stay authorization or justifies a step-down.
ASAM vs other placement frameworks
ASAM is the placement standard for substance use disorders. For primary mental health populations, two other frameworks dominate:
LOCUS (Level of Care Utilization System) is the adult mental health placement framework. Like ASAM, it uses dimensional scoring across multiple domains, but the dimensions are calibrated for primary psychiatric conditions rather than addiction. Most commercial payers accept LOCUS for adult mental health placements.
CALOCUS (Child and Adolescent Level of Care Utilization System) is the pediatric and adolescent equivalent. CALOCUS-CASII is the same instrument with slightly different scoring guidance.
Co-occurring programs typically reference ASAM for the SUD components and LOCUS or CALOCUS for the primary mental health components, then integrate the two into a unified placement recommendation. Programs serving co-occurring populations should be fluent in both frameworks and document both clearly during initial assessment and continued-stay reviews.
Frequently Asked Questions About ASAM Criteria
What are the six ASAM dimensions?
1) Acute intoxication or withdrawal potential, 2) Biomedical conditions, 3) Emotional, behavioral, or cognitive, 4) Readiness to change, 5) Relapse or continued use potential, 6) Recovery environment. All six dimensions are assessed at admission and at every continued-stay review.
How many ASAM levels of care are there?
Five core levels (0.5, 1, 2, 3, 4) with multiple sub-levels: 2.1 IOP, 2.5 PHP, 3.1 clinically managed low-intensity residential, 3.3 medium-intensity, 3.5 high-intensity, 3.7 medically monitored, 4.0 medically managed. Withdrawal management has its own parallel levels (1-WM through 4-WM).
How do payers use ASAM in authorization decisions?
Most commercial payers and Medicaid plans require ASAM-based clinical justification at every authorization touchpoint — initial, concurrent, and discharge. Strong ASAM documentation is the single most important predictor of authorization wins and successful peer-to-peer reviews.
What changed in the ASAM 4th edition (2024)?
The 4th edition reorganized the criteria into a more clinical-decision-tree format, expanded the dimensional assessment to include social determinants, updated co-occurring guidelines, and integrated newer pharmacotherapy considerations for opioid use disorder.
Is ASAM the same as DSM?
No. DSM (Diagnostic and Statistical Manual) is the diagnostic system for what disorder a patient has. ASAM is the placement system for what level of care that patient needs. They work together — DSM diagnosis informs ASAM placement.
How does ASAM apply outside addiction treatment?
ASAM was designed for addiction. For primary mental health programs (eating disorder, anxiety, depression), most payers and accreditors use the LOCUS or CALOCUS framework. Co-occurring programs typically reference ASAM.